Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Articles
Evolving Immuno-Oncology Strategies in Renal-Cell Carcinoma
By
Wayne Kuznar
Web Exclusives
,
Immunotherapy
Read More ›
Personalized Neoadjuvant Immunotherapy Combinations Improve Outcomes in Stage III Melanoma
By
Wayne Kuznar
Melanoma/Skin Cancer
,
Web Exclusives
Read More ›
Personalizing Immunotherapy in NSCLC Using PD-L1 and Tumor Mutation Burden as Biomarkers
By
Wayne Kuznar
Lung Cancer
,
Web Exclusives
Read More ›
Dual-Specific CAR T-Cell Therapy Targets CD19 and CD22 in Patients with Acute Lymphoblastic Leukemia
By
Chase Doyle
Web Exclusives
,
Immunotherapy
Read More ›
The Quality–Cost Connection in Cancer Care: Lessons from Oncology Practices in Washington State
By
Meg Barbor, MPH
Web Exclusives
Read More ›
March 08, 2019 – FDA Approvals, News & Updates
Web Exclusives
,
FDA Approvals, News & Updates
Read More ›
One Oncologist’s Firsthand Experience with Serious Illness: What Your Patients Want
By
Meg Barbor, MPH
Web Exclusives
,
Patient Navigation
Read More ›
Targeted Intervention Reduces Opioid Use by Nearly 50% After Urologic Oncology Surgery
By
Meg Barbor, MPH
Symptom Management
,
Web Exclusives
Read More ›
Targeted Intervention Reduces Opioid Use by Nearly 50% After Urologic Oncology Surgery
Symptom Management
Read More ›
Addressing Financial Toxicity Through Systematic Change
By
Meg Barbor, MPH
Web Exclusives
,
Financial Toxicity
Read More ›
Page 4 of 62
1
2
3
4
5
6
7